Company Filing History:
Years Active: 2010
Title: Christopher Murray: Innovator in Allosteric Hemoglobin Modifiers
Introduction
Christopher Murray is an accomplished inventor based in Arlington, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of allosteric hemoglobin modifiers. His innovative work focuses on creating compositions that are free from impurities, which is crucial for enhancing the efficacy of hemoglobin-based therapies.
Latest Patents
Murray holds a patent for "Compositions of allosteric hemoglobin modifiers and methods of making the same." This invention provides novel compositions that are substantially free of impurities, specifically polymeric impurities. The patent outlines methods for preparing these allosteric hemoglobin modifiers, ensuring that they contain less than 100 ppm of polymeric impurities generated during the preparation process. The purification methods described in the patent involve extracting the crude composition with solvents like methylisobutyl ketone (MIBK) and recrystallizing the synthesized product to reduce impurities.
Career Highlights
Christopher Murray is affiliated with Virginia Commonwealth University, where he continues to advance research in his field. His work has garnered attention for its potential applications in medical therapies, particularly in improving the performance of hemoglobin-based products.
Collaborations
Murray has collaborated with notable colleagues, including Al Quick and Antonio M Santos. These partnerships have contributed to the development and refinement of his innovative approaches in biochemistry.
Conclusion
Christopher Murray's contributions to the field of allosteric hemoglobin modifiers highlight his role as a leading inventor in biochemistry. His patented innovations pave the way for advancements in medical therapies that rely on hemoglobin.